ArticleOncology letters2018

Overexpression of peroxiredoxin-3 and -5 is a potential biomarker for prognosis in endometrial cancer.

Jung Mi Byun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.